By
The global diabetic footwear market size is projected to reach $14,183.7 million by 2031, registering a CAGR of 7.9% from 2022 to 2031.
The global diabetic footwear market is rapidly expanding, driven by the increasing prevalence of diabetes, rising awareness of foot care, and advances in healthcare solutions tailored for diabetic patients. This market is essential for providing patients with comfortable, supportive, and therapeutic footwear that helps prevent foot ulcers, infections, and other complications that can arise due to diabetes.
Overview of the Diabetic Footwear Market
Diabetic footwear, also known as therapeutic shoes, is specially designed for diabetic patients to reduce the risk of skin breakdown, particularly in individuals with pre-existing foot deformities or neuropathy. These shoes offer additional cushioning, support, and space to accommodate special insoles or custom orthotics.
According to the report, the global Diabetic footwear market accounted for $5.53 billion in 2018 and is expected to reach $9.90 billion in 2025, registering a CAGR of 8.7% from 2018 to 2025.
Key Market Drivers
Rising Diabetic Population
The growing prevalence of diabetes worldwide is a major driver for the diabetic footwear market. The International Diabetes Federation (IDF) estimates that over 537 million adults globally are living with diabetes as of 2021, and this number is expected to rise to 643 million by 2030. As the diabetic population grows, the demand for therapeutic solutions, including specialized footwear, is increasing rapidly.
Increased Awareness of Diabetic Foot Care
There is a growing awareness among diabetic patients and healthcare providers about the importance of foot care. Many diabetic patients are prone to foot complications due to poor circulation and neuropathy, which can lead to ulcers and, in severe cases, amputations. Proper footwear can help prevent these complications, making diabetic footwear a necessary part of diabetic care.
Technological Advancements
Recent technological advancements in the design and manufacturing of diabetic footwear have made them more effective, comfortable, and fashionable. New materials, advanced cushioning systems, and custom orthotics integration have enhanced the therapeutic value of diabetic shoes, further driving market growth.
Government Initiatives and Reimbursement Policies
Many governments and healthcare systems are implementing policies that promote diabetic foot care, including subsidizing or reimbursing the cost of diabetic footwear. In countries like the U.S., Medicare covers the cost of diabetic footwear for eligible patients, which has significantly boosted the market.
